ndustry, medical professionals, and other stakeholders have weighed in on the FDA-backed public-private plan to create the National Medical Device Postmarket Surveillance System. Reaction was mainly positive, with commenters highlighting various challenges or issues to consider carefully as part of the effort. The initiative, led by the Planning Board, is outlined in a report published in February 2015 and is expected to take several years to implement.